Similar articles

• Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.

  Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA. Kogan R, et al. Pediatr Pulmonol. 2003 Feb;35(2):91-8. doi: 10.1002/ppul.10180. Pediatr Pulmonol. 2003. PMID: 12526069 Clinical Trial.
• Azithromycin extended-release (Zmax) for sinusitis and pneumonia.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2005 Sep 26;47(1218):78-80. Med Lett Drugs Ther. 2005. PMID: 16186790 No abstract available.
• Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.

  Rahav G, Fidel J, Gibor Y, Shapiro M. Rahav G, et al. Int J Antimicrob Agents. 2004 Aug;24(2):181-4. doi: 10.1016/j.ijantimicag.2004.01.011. Int J Antimicrob Agents. 2004. PMID: 15288319 Clinical Trial.
• Community-acquired respiratory infections: spectrum of organisms and treatment.

  McKellar PP. McKellar PP. J Med Liban. 2000 Jul-Aug;48(4):264-9. J Med Liban. 2000. PMID: 11214199 Review.
• Is it possible to blind a trial for community-acquired pneumonia?

  Boucher HW. Boucher HW. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S210-5. doi: 10.1086/591428. Clin Infect Dis. 2008. PMID: 18986292 Review.